Brought to you by 
OphthaliX files for its IPO on NYSE
14 May 2015
Executive Summary
OphthaliX Inc. (ophthalmic therapeutics) has filed for its initial public offering. It plans to list shares on NYSE (the company already trades on the OTC market).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Preliminary
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
OphthaliX files for its IPO on NYSE
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice